Critical appraisal of the use of regorafenib in the management of colorectal cancer

The lack of valid clinical management options for patients affected by metastatic colorectal cancer, which has progressed after all approved standard treatments, has lead to research into new active molecules. Regorafenib is an oral small-molecule multi kinase inhibitor, binding to several intracell...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Festino, Lucia, Fabozzi, Alessio, Manzo, Anna, Gambardella, Valentina, Martinelli, Erika, Troiani, Teresa, De Vita, Ferdinando, Orditura, Michele, Ciardiello, Fortunato, Morgillo, Floriana
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2013
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3628528/
https://ncbi.nlm.nih.gov/pubmed/23610528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S34281
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars